000 | 01513 a2200409 4500 | ||
---|---|---|---|
005 | 20250518061911.0 | ||
264 | 0 | _c20200203 | |
008 | 202002s 0 0 eng d | ||
022 | _a2050-084X | ||
024 | 7 |
_a10.7554/eLife.48648 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSkorput, Alexander Gj | |
245 | 0 | 0 |
_aThe NKCC1 antagonist bumetanide mitigates interneuronopathy associated with ethanol exposure in utero. _h[electronic resource] |
260 |
_beLife _c09 2019 |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAlcohol Drinking _xadverse effects |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBumetanide _xadministration & dosage |
650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFetal Alcohol Spectrum Disorders _xphysiopathology |
650 | 0 | 4 |
_aGABAergic Neurons _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aPrefrontal Cortex _xdrug effects |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aPregnancy Complications _xphysiopathology |
650 | 0 | 4 |
_aSodium Potassium Chloride Symporter Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aSolute Carrier Family 12, Member 2 _xmetabolism |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_agamma-Aminobutyric Acid _xmetabolism |
700 | 1 | _aLee, Stephanie M | |
700 | 1 | _aYeh, Pamela Wl | |
700 | 1 | _aYeh, Hermes H | |
773 | 0 |
_teLife _gvol. 8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.7554/eLife.48648 _zAvailable from publisher's website |
999 |
_c30135606 _d30135606 |